Daily Archives: March 13, 2007

A Note on Approvable Letters

An approvable letter was issued this week for Accretropin, Cangene‘s recombinant human growth hormone ("rhGH").   "In its action letter, the FDA requested additional support data regarding manufacturing processes. As fulfilling this requirement does not involve further clinical trials, Cangene anticipates … Continue reading

Posted in Approvable Letters | Comments Off